Whole genome sequencing in paediatric channelopathy and cardiomyopathy
Frontiers in Cardiovascular Medicine · 20.03.2024 · 11
DOI: 10.3389/fcvm.2024.1335527 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 20.03.2024. Verfasst von Sit Yee Kwok und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, Hong Kong SAR, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Precision medicine in paediatric cardiac channelopathy and cardiomyopathy has a rapid advancement over the past years. Compared to conventional gene panel and exome-based testing, whole genome sequencing (WGS) offers additional coverage at the promoter, intronic regions and the mitochondrial genome. However, the data on use of WGS to evaluate the genetic cause of these cardiovascular conditions in children and adolescents are limited.
Methods
In a tertiary paediatric cardiology center, we recruited all patients diagnosed with cardiac channelopathy and cardiomyopathy between the ages of 0 and 18 years old, who had negative genetic findings with prior gene panel or exome-based testing. After genetic counselling, blood samples were collected from the subjects and both their parents for WGS analysis.
Results
A total of 31 patients (11 cardiac channelopathy and 20 cardiomyopathy) were recruited. Four intronic splice-site variants were identified in three cardiomyopathy patients, which were not identified in previous whole exome sequencing. These included a pathogenic variant in TAFAZZIN:c.284+5G>A (Barth syndrome), a variant of unknown significance (VUS) in MYBPC3:c.1224-80G>A and 2 compound heterozygous LP variants in LZTR1 ( LZTR1:c.1943-256C>T and LZTR1:c1261-3C>G ) in a patient with clinical features of RASopathy. There was an additional diagnostic yield of 1.94% using WGS for identification of intronic variants, on top of conventional gene testing.
Conclusion
WGS plays a role in identifying additional intronic splice-site variants in paediatric patients with isolated cardiomyopathy. With the demonstrated low extra yield of WGS albeit its ability to provide potential clinically important information, WGS should be considered in selected paediatric cases of cardiac channelopathy and cardiomyopathy in a cost-effective manner.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, Hong Kong SAR, China.
- Department of Paediatrics and Adolescent Medicine, School of Clinical Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.
- Clinical Genetics Service Unit, Hong Kong Children's Hospital, Hong Kong, Hong Kong SAR, China.
Zitieren
APA
Kwok, S. Y., Kwong, A. K. Y., Shi, J. Z., Shih, C. F. Y., Lee, M., Mak, C. C. Y., Chui, M., Tsao, S., & Chung, B. H. Y. (2024). Whole genome sequencing in paediatric channelopathy and cardiomyopathy. Frontiers in Cardiovascular Medicine, 11. https://doi.org/10.3389/fcvm.2024.1335527
Vancouver
Kwok SY, Kwong AKY, Shi JZ, Shih CFY, Lee M, Mak CCY, et al. Whole genome sequencing in paediatric channelopathy and cardiomyopathy. Frontiers in Cardiovascular Medicine. 2024;11. doi:10.3389/fcvm.2024.1335527
BibTeX
@article{Kwok2024,
author = {Kwok, Sit Yee and Kwong, Anna Ka Yee and Shi, Julia Zhuo and Shih, Connie Fong Ying and Lee, Mianne and Mak, Christopher C Y and Chui, Martin and Tsao, Sabrina and Chung, Brian Hon Yin},
title = {Whole genome sequencing in paediatric channelopathy and cardiomyopathy},
journal = {Frontiers in Cardiovascular Medicine},
year = {2024},
volume = {11},
doi = {10.3389/fcvm.2024.1335527}
}
EUVIMED